Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 28.20% is in line with its 5-year average of 26.47%, near the low end of its 5-year range (20.11%–71.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.68% below its 12-month average of 29.90%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 28.20%.
DEBT TO ASSETS RATIO
28.20%
DEBT TO ASSETS RATIO AVG TTM
29.90%
DEBT TO ASSETS RATIO AVG 3Y
27.48%
DEBT TO ASSETS RATIO AVG 5Y
26.47%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.68%
CURRENT VS 3Y AVG
+2.62%
CURRENT VS 5Y AVG
+6.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+31233.11%
vs the sector median at left
NEXGEL, Inc.
Market Cap
$1.47M
Debt to Assets Ratio
28.20%
TTM Avg
29.90%
3Y Avg
27.48%
5Y Avg
26.47%
Market Cap
$1.52M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.39M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.34M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.47M | 28.20% | 29.90% | 27.48% | 26.47% |
| Curis, Inc. (CRIS)vs › | $1.46M | 0.06% | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | 0.38% | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | 0.15% | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 0.02% | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | 0.47% | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | 0.01% | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.04% | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.32M | 0.00% | N/A | N/A | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | 0.00% | N/A | N/A | N/A |
Debt/Assets
28.2%
Debt/Equity
1.51
Current Ratio
0.43
Interest Coverage
-98.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 28.20% |
| 2026-03-31 | 36.95% |
| 2025-12-31 | 29.52% |
| 2025-09-30 | 27.47% |
| 2025-06-30 | 27.34% |
| 2025-03-31 | 26.27% |
| 2024-12-31 | 25.73% |
| 2024-09-30 | 30.82% |
| 2024-06-30 | 30.64% |
| 2024-03-31 | 29.58% |
| 2023-12-31 | 28.11% |
| 2023-09-30 | 23.88% |
| 2023-06-30 | 22.21% |
| 2023-03-31 | 23.71% |
| 2022-12-31 | 20.11% |
| 2022-09-30 | 20.73% |
| 2022-06-30 | 24.67% |
| 2022-03-31 | 21.92% |
| 2021-12-31 | 25.11% |
| 2021-09-30 | 71.87% |
| 2021-06-30 | 71.39% |
| 2021-03-31 | 41.10% |
| 2020-12-31 | 56.58% |
| 2020-09-30 | 56.49% |
| 2020-06-30 | 56.18% |
| 2020-03-31 | 45.52% |
| 2019-12-31 | 48.52% |
| 2019-09-30 | 57.89% |
| 2019-06-30 | 53.98% |
| 2019-03-31 | 59.30% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2017-12-31 | 0.00% |
